AGA has published two new treatment guidelines in Gastroenterology providing a personalized approach for treating your patients with approved drug treatments for irritable bowel syndrome (IBS) with constipation (IBS-C) or IBS with diarrhea (IBS-D).
The guidelines outline, for the first time, when to use newly introduced IBS drugs, when to rely on old drugs approved by the FDA and when to use over the counter drugs. With more treatments available, you can now tailor a personalized approach based on the symptoms your IBS patient is experiencing.
Join us for a webinar on each of the guidelines
Please join the guideline authors for Gastro Bites on IBS-C and IBS-D. During each of the 30-minute webinars, they will explain the guidance in greater detail and answer your questions about applying these guidelines in your practice.
- Register for Gastro Bites: Irritable bowel syndrome with constipation (IBS-C) taking place on Thursday, July 7 at noon EDT
- Register for Gastro Bites: Irritable bowel syndrome with diarrhea (IBS-D) taking place on Thursday, July 21 at noon EDT
